Benjamin joined the Centre for Biomedical Ethics in 2008. He was previously a Research Associate at the Centre for Ethics in Medicine, University of Bristol, UK.
He read for a Doctorate in Medical Ethics (awarded in 2004) and completed a two-year Postdoctoral Fellowship at the University of Bristol (2004-6), both funded by the Wellcome Trust’s Biomedical Ethics Programme.
He has coordinated a number of projects, including an ethics review for the UK’s Department of Trade and Industry Foresight project: ‘Brain Science, Addiction and Drugs’ (2004-5); a commissioned report on “‘Public Interest’ and ‘Public Good’ as Applied to UK Biobank Access Decision-Making” for the UK Biobank’s Ethics and Governance Council (2007-8); and an international multi-centre project on ‘New Developments in Neuroscience and Genetics’ (2007-8). This latter project was funded by the European Monitoring Centre for Drugs and Drug Addiction, an agency of the European Union.
Benjamin is an Honorary Associate at the ESRC Centre for Economic and Social Aspects of Genomics (Cesagen); and has been a Visiting Fellow at the Centre for Biomedical Ethics, at the National University of Singapore (2007 & 2008), University of Brisbane (2008), and the Hastings Centre, New York (2005).
His primary research interests are in stem cell science and ethics; 'neuroethics', drugs (mis)use and addiction research. His research also focuses on the development of jurisprudential and political theory in the use of human rights concepts in biotechnology and bio-medicine.
